Search Results - "Baggs, James"

Refine Results
  1. 1

    Estimating National Trends in Inpatient Antibiotic Use Among US Hospitals From 2006 to 2012 by Baggs, James, Fridkin, Scott K, Pollack, Lori A, Srinivasan, Arjun, Jernigan, John A

    Published in JAMA internal medicine (01-11-2016)
    “…The rising threat of antibiotic resistance and other adverse consequences resulting from the misuse of antibiotics requires a better understanding of…”
    Get more information
    Journal Article
  2. 2

    Multidrug-Resistant Bacterial Infections in U.S. Hospitalized Patients, 2012–2017 by Jernigan, John A, Hatfield, Kelly M, Wolford, Hannah, Nelson, Richard E, Olubajo, Babatunde, Reddy, Sujan C, McCarthy, Natalie, Paul, Prabasaj, McDonald, L. Clifford, Kallen, Alex, Fiore, Anthony, Craig, Michael, Baggs, James

    Published in The New England journal of medicine (02-04-2020)
    “…This article provides U.S. national estimates for six common nosocomial pathogens. The incidence of infection decreased for four (MRSA, vancomycin-resistant…”
    Get full text
    Journal Article
  3. 3

    Risk of Subsequent Sepsis Within 90 Days After a Hospital Stay by Type of Antibiotic Exposure by Baggs, James, Jernigan, John A, Halpin, Alison Laufer, Epstein, Lauren, Hatfield, Kelly M, McDonald, L Clifford

    Published in Clinical infectious diseases (19-03-2018)
    “…We examined the risk of sepsis within 90 days after discharge from a previous hospital stay by type of antibiotic received during the previous stay. We…”
    Get full text
    Journal Article
  4. 4

    Candida auris‒Associated Hospitalizations, United States, 2017-2022 by Benedict, Kaitlin, Forsberg, Kaitlin, Gold, Jeremy A W, Baggs, James, Lyman, Meghan

    Published in Emerging infectious diseases (01-07-2023)
    “…Using a large US hospital database, we describe 192 Candida auris‒associated hospitalizations during 2017-2022, including 38 (20%) C. auris bloodstream…”
    Get full text
    Journal Article
  5. 5

    Risk of Intussusception after Monovalent Rotavirus Vaccination by Weintraub, Eric S, Baggs, James, Duffy, Jonathan, Vellozzi, Claudia, Belongia, Edward A, Irving, Stephanie, Klein, Nicola P, Glanz, Jason M, Jacobsen, Steven J, Naleway, Allison, Jackson, Lisa A, DeStefano, Frank

    Published in The New England journal of medicine (06-02-2014)
    “…Vaccination has been associated with a decline in rotavirus-associated illness, but concern about intussusception remains. In this CDC report, the monovalent…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Risk of Intussusception Following Administration of a Pentavalent Rotavirus Vaccine in US Infants by Shui, Irene M, Baggs, James, Patel, Manish, Parashar, Umesh D, Rett, Melisa, Belongia, Edward A, Hambidge, Simon J, Glanz, Jason M, Klein, Nicola P, Weintraub, Eric

    “…CONTEXT Current rotavirus vaccines were not associated with intussusception in large prelicensure trials. However, recent postlicensure data from international…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Extended-Spectrum Beta-Lactamase Producing Enterobacterales Infections in the United States, 2012-2021 by Maillis, Alexander, McCarthy, Natalie, Wolford, Hannah, Baggs, James, Reddy, Sujan, Lutgring, Joseph

    “…Background: The 2022 Special Report: COVID-19 U.S. Impact on Antimicrobial Resistance identified continued increases in the rate of extended- spectrum…”
    Get full text
    Journal Article
  10. 10

    COVID-19 Vaccine Safety in Adolescents Aged 12-17 Years - United States, December 14, 2020-July 16, 2021 by Hause, Anne M, Gee, Julianne, Baggs, James, Abara, Winston E, Marquez, Paige, Thompson, Deborah, Su, John R, Licata, Charles, Rosenblum, Hannah G, Myers, Tanya R, Shimabukuro, Tom T, Shay, David K

    “…As of July 30, 2021, among the three COVID-19 vaccines authorized for use in the United States, only the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine is…”
    Get full text
    Journal Article Newsletter
  11. 11

    Childhood vaccines and Kawasaki disease, Vaccine Safety Datalink, 1996-2006 by Abrams, Joseph Y, Weintraub, Eric S, Baggs, James M, McCarthy, Natalie L, Schonberger, Lawrence B, Lee, Grace M, Klein, Nicola P, Belongia, Edward A, Jackson, Michael L, Naleway, Allison L, Nordin, James D, Hambidge, Simon J, Belay, Ermias D

    Published in Vaccine (03-01-2015)
    “…Highlights • Longitudinal, multi-site study on 1.7 million children for 4.4 million person-years. • No evidence for increased rate of Kawasaki disease…”
    Get full text
    Journal Article
  12. 12

    Empiric antibiotic selection for community-acquired pneumonia in US hospitals, 2013–2020 by Wolford, Hannah, Attell, Brandon, Baggs, James, Reddy, Sujan, Kabbani, Sarah, Neuhauser, Melinda, Hicks, Lauri

    “…Background: Community-acquired pneumonia (CAP) is a common indication for antibiotic prescribing in hospitalized patients. Professional societies’ clinical…”
    Get full text
    Journal Article
  13. 13

    Fluconazole resistance in non- albicans Candida species in the United States, 2012-2021 by Jenkins, Emily, Lyman, Meghan, Jackson, Brendan, Lockhart, Shawn, Wolford, Hannah, Reddy, Sujan, Baggs, James

    “…Background: Candida spp can cause a variety of infections known as candidiasis, ranging from severe invasive infections to superficial mucosal infections of…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Organism-specific Trends in Carbapenem-resistant Enterobacterales Infections in a Cohort of Hospitalized Patients, 2012–2022 by Khan, Mohammed, Wolford, Hannah, McCarthy, Natalie, Olubajo, Babatunde, Bishop, Jonathan, Baggs, James, Lutgring, Joseph, Reddy, Sujan, Walters, Maroya

    “…Background: Carbapenem-resistant Enterobacterales (CRE) infections are an urgent public health threat. An estimated 12,700 CRE (including E. coli, Klebsiella…”
    Get full text
    Journal Article
  16. 16

    Safety Monitoring of an Additional Dose of COVID-19 Vaccine - United States, August 12-September 19, 2021 by Hause, Anne M, Baggs, James, Gee, Julianne, Marquez, Paige, Myers, Tanya R, Shimabukuro, Tom T, Shay, David K

    “…On August 12, 2021, the Food and Drug Administration (FDA) amended Emergency Use Authorizations (EUAs) for the Pfizer-BioNTech and Moderna COVID-19 vaccines to…”
    Get full text
    Journal Article Newsletter
  17. 17
  18. 18

    Postlicensure Monitoring of Intussusception After RotaTeq Vaccination in the United States, February 1, 2006, to September 25, 2007 by Haber, Penina, Patel, Manish, Izurieta, Hector S, Baggs, James, Gargiullo, Paul, Weintraub, Eric, Cortese, Margaret, Braun, M. Miles, Belongia, Edward A, Miller, Elaine, Ball, Robert, Iskander, John, Parashar, Umesh D

    Published in Pediatrics (Evanston) (01-06-2008)
    “…In 1999, a previous rotavirus vaccine (RotaShield; Wyeth Laboratories, Marietta, PA) was withdrawn from the US market after postlicensure monitoring identified…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Temporal trends in urine-culture rates in the US acute-care hospitals, 2017–2020 by Kazakova, Sophia, McCarthy, Natalie, Baggs, James, Hatfield, Kelly, Wolford, Babatunde, Olubajo, Babatunde, Jernigan, John, Reddy, Sujan

    “…Background: Previously, we reported decreasing postadmission urine-culture rates in hospitalized patients between 2012 and 2017, indicating a possible decrease…”
    Get full text
    Journal Article